A detailed history of Emerald Mutual Fund Advisers Trust transactions in Atri Cure, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 249,504 shares of ATRC stock, worth $10.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
249,504
Previous 255,241 2.25%
Holding current value
$10.1 Million
Previous $5.81 Million 20.39%
% of portfolio
0.39%
Previous 0.33%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$20.34 - $29.5 $116,690 - $169,241
-5,737 Reduced 2.25%
249,504 $7 Million
Q2 2024

Aug 06, 2024

SELL
$19.86 - $29.09 $329,139 - $482,108
-16,573 Reduced 6.1%
255,241 $5.81 Million
Q1 2024

May 08, 2024

SELL
$28.21 - $37.78 $2.55 Million - $3.42 Million
-90,545 Reduced 24.99%
271,814 $8.27 Million
Q4 2023

Feb 05, 2024

SELL
$32.99 - $43.25 $1.62 Million - $2.12 Million
-49,041 Reduced 11.92%
362,359 $12.9 Million
Q1 2023

May 04, 2023

BUY
$35.87 - $47.22 $204,458 - $269,154
5,700 Added 1.4%
411,400 $17.1 Million
Q4 2022

Feb 03, 2023

BUY
$33.48 - $47.45 $1.9 Million - $2.69 Million
56,620 Added 16.22%
405,700 $18 Million
Q3 2022

Oct 25, 2022

SELL
$38.25 - $52.62 $1.08 Million - $1.49 Million
-28,259 Reduced 7.49%
349,080 $13.6 Million
Q2 2022

Jul 29, 2022

BUY
$35.1 - $66.01 $655,422 - $1.23 Million
18,673 Added 5.21%
377,339 $15.4 Million
Q1 2022

Apr 29, 2022

SELL
$57.43 - $71.39 $4.55 Million - $5.66 Million
-79,313 Reduced 18.11%
358,666 $23.6 Million
Q4 2021

Feb 02, 2022

SELL
$63.4 - $87.14 $3.14 Million - $4.31 Million
-49,483 Reduced 10.15%
437,979 $30.5 Million
Q3 2021

Oct 28, 2021

SELL
$69.28 - $84.46 $3.63 Million - $4.43 Million
-52,394 Reduced 9.71%
487,462 $33.9 Million
Q1 2021

Apr 29, 2021

BUY
$53.79 - $66.98 $1.17 Million - $1.46 Million
21,820 Added 4.21%
539,856 $35.4 Million
Q4 2020

Jan 29, 2021

BUY
$34.56 - $57.55 $1.42 Million - $2.36 Million
40,972 Added 8.59%
518,036 $28.8 Million
Q3 2020

Oct 28, 2020

SELL
$38.36 - $46.91 $728 - $891
-19 Reduced -0.0%
477,064 $19 Million
Q2 2020

Jul 28, 2020

BUY
$31.78 - $51.19 $1.92 Million - $3.09 Million
60,431 Added 14.5%
477,083 $21.4 Million
Q1 2020

Apr 30, 2020

SELL
$24.49 - $43.84 $422,697 - $756,678
-17,260 Reduced 3.98%
416,652 $14 Million
Q3 2018

Oct 31, 2018

BUY
$27.62 - $35.58 $165,443 - $213,124
5,990 Added 1.4%
433,912 $15.2 Million
Q1 2018

Apr 26, 2018

SELL
$15.05 - $21.03 $920,819 - $1.29 Million
-61,184 Reduced 12.51%
427,922 $8.78 Million
Q4 2017

Feb 06, 2018

SELL
$17.69 - $23.44 $178,385 - $236,368
-10,084 Reduced 2.02%
489,106 $8.92 Million
Q3 2017

Oct 30, 2017

BUY
$20.0 - $24.23 $9.98 Million - $12.1 Million
499,190
499,190 $11.2 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.88B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.